FOR many years disease activity in rheumatoid arthritis (RA) has been measured by an
enormous number of different variables as a single golden standard for measuring disease …

Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA)
clinical trials, as well as to recommend specific methods for assessing each outcome …

Rheumatoid arthritis (RA) clinical trials often include at least 10 measures of disease activity
(eg, tender and swollen joint counts, erythrocyte sedimentation rate, patient pain, grip …

Objective To make recommendations on how to report disease activity in clinical trials of
rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) …

Over the years, the growing need to standardize methodologies in rheumatoid arthritis, to
improve the clinical management and evaluation of the effectiveness of treatments, has led …

Disease activity in rheumatoid arthritis is not easily measured. The validityof current
measures has been reviewed. Recent international efforts have resulted in consensus over …

Objective To compare the value of reporting treatment effects in rheumatoid arthritis (RA) as
relative change from baseline (eg, American College of Rheumatology [ACR] responder …

There is no single 'gold standard'quantitative measure to assess and monitor the clinical
status in patients with rheumatoid arthritis (RA). Therefore, a variety of measures have been …

In clinical trials on the effectiveness of disease-modifying antirheumatic drugs (DMARDs) in
patients with rheumatoid arthritis (RA), it is common to apply a large number of endpoint …

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease with peripheral
synovitis as its main manifestation. The presentation of the disease and the course during …